The FDA has issued communications addressing risks associated with some compounded GLP-1 products, and in early 2026, FDA issued warning letters to certain telehealth companies regarding marketing claims about compounded GLP-1 products
More Scientific Evidence No scientific evidence supports the idea that prolonged stress leads to exhausted adrenal glands
Semaglutide is marketed as Ozempic for type 2 diabetes, Wegovy for chronic weight management, and Rybelsus as an oral tablet for type 2 diabetes
Knowing who actually provides the medical care, which pharmacies fill the prescriptions, what the refund policy says before you pay, and what "compounded" means in the current regulatory environment are no longer optional details
Additionally, some patients hypothesise that weight loss and metabolic changes induced by Ozempic may alter thermoregulation, though this mechanism is not well-established in clinical evidence